3rd Quarter - Report

LUNDBECK LLC for LUNDBECK LLC

Firm
Client
Income
—
Expenses
$160,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues regarding Pharmacy Benefit Managers Drug Affordability - H.R. 830, S. 1375 - The HELP Copays Act Step therapy reform - S. 6452 & H.R. 2630- The Safe Step Act Migraine care - Fiscal Year 2024 Military Construction, Veterans Affairs, and Related Agencies Funding Bill Neuroscience Drug Program - Fiscal Year 2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Funding Act R & D Tax Credit

LobbyistCovered position, as disclosed
HAYLEY ALEXANDER New —
HEATHER STRAWN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2630 (118th), H.R. 830 (118th), S. 6452 (118th), S. 1375 (118th)

Medicare/Medicaid MMM

Issues pertaining to the 340B Drug Discount Program Issues pertaining to the implementation of the Inflation Reduction Act of 2022 Issues pertaining to Pharmacy Benefit Managers Issues pertaining to CMS Coverage of APS in LTC Alzheimers screening in Medicare - S. 2379 & H.R. 4752 - The Change Act of 2023 Issues pertaining to Medicares Six Protected Classes policy

LobbyistCovered position, as disclosed
HAYLEY ALEXANDER New —
HEATHER STRAWN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2379 (118th), H.R. 4752 (118th)

Taxation/Internal Revenue Code TAX

R & D tax credit

LobbyistCovered position, as disclosed
HEATHER STRAWN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.